🇺🇸 FDA
Patent

US 9801938

Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

granted A61KA61K2039/507A61K39/40

Quick answer

US patent 9801938 (Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists) held by FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/507, A61K39/40, A61P, A61P25/00